Today: 29 April 2026
Browse Category

AMS:NBIS 7 November 2025 - 13 April 2026

Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk

Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk

Nebius Group shares climbed 7.4% to $155.74 by midday Monday after Bank of America raised its price target to $175, despite Freedom Capital Markets downgrading the stock to Hold. The Amsterdam-based AI infrastructure firm recently secured a five-year deal with Meta worth up to $27 billion and holds over $40 billion in supply contracts with Microsoft and Meta. Nebius also closed $4.34 billion in convertible debt and sold $2 billion in warrants to Nvidia.
13 April 2026
·
Nebius (NBIS) stock rises in choppy session as AI cloud spending stays in focus

Nebius (NBIS) stock rises in choppy session as AI cloud spending stays in focus

Nebius Group N.V. shares rose 1.8% to $99.70 Monday, trading as high as $101.12 on volume of 7.5 million shares. The Amsterdam-based cloud provider, which rents out Nvidia chips and data-center capacity, recently forecast an end-2026 revenue run-rate of $7–9 billion. Investors remain focused on Nebius’s build pace and financing. Nvidia reports quarterly results Wednesday.
23 February 2026
··
Nebius stock ticks up in premarket as NBIS investors brace for earnings, Tavily deal details

Nebius stock ticks up in premarket as NBIS investors brace for earnings, Tavily deal details

Nebius Group N.V. shares rose 0.4% to $88.98 in premarket trading Thursday after falling 3.46% in the previous session. The Amsterdam-based AI cloud firm will report fourth-quarter and full-year results before the U.S. market opens. Terms of its Tavily acquisition remain undisclosed, though Bloomberg reported a $275 million price. A live webcast is set for 8:00 a.m. Eastern.
12 February 2026
··
Nebius Group (NBIS) stock price jumps 8% as earnings week sharpens focus on AI cloud buildout

Nebius Group (NBIS) stock price jumps 8% as earnings week sharpens focus on AI cloud buildout

Nebius Group N.V. shares jumped 8.3% to $93.26 in heavy trading Monday, ahead of its quarterly results due Feb. 12. The Amsterdam-based AI cloud firm’s stock swung sharply as investors weighed execution risks on major GPU infrastructure contracts with Meta and Microsoft. Wall Street expects another loss, with consensus at a 44-cent per-share deficit on $232.2 million in revenue.
9 February 2026
·····
Nebius (NBIS) stock jumps 16% into weekend as AI trade whipsaws; earnings next week in focus

Nebius (NBIS) stock jumps 16% into weekend as AI trade whipsaws; earnings next week in focus

Nebius shares jumped 16.6% to $86.10 on Friday, rebounding from a 10.3% drop Thursday. The company will report fourth-quarter and full-year 2025 results before the market opens on Feb. 12. U.S. jobs and inflation data are due next week after a delay from a government shutdown. Recent swings in Nebius stock followed volatility in AI-linked tech names after Alphabet’s spending update.
7 February 2026
··
Nebius (NBIS) stock drops in premarket as tariff jitters hit high-growth tech

Nebius (NBIS) stock drops in premarket as tariff jitters hit high-growth tech

Nebius Group N.V. shares fell 4.6% to $103.73 in U.S. premarket trading Tuesday after closing at $108.73, with 390,000 shares traded before the open. The drop tracked a broader tech selloff as U.S. index futures slid on tariff threats from President Trump. Nebius recently posted a quarterly loss over $100 million and capital spending of $955.5 million, despite revenue rising to $146.1 million.
20 January 2026
··
Nebius Group (NBIS) stock falls 3% as AI cloud trade cools; what investors watch next

Nebius Group (NBIS) stock falls 3% as AI cloud trade cools; what investors watch next

Nebius Group N.V. shares fell 3.3% to $101.98 at Wednesday’s close, reversing earlier gains after volatile trading. The drop followed a near 10% surge Monday amid news on Nvidia chip integration and data center plans. Broader AI stocks slipped as the Nasdaq-tracking QQQ Trust and Nvidia both declined about 1%. Nebius will host a webinar on its Aether 3.1 release on Jan. 29.
15 January 2026
···
Nebius (NBIS) stock slides 3% as tech weakens; investors eye next AI-cloud catalysts

Nebius (NBIS) stock slides 3% as tech weakens; investors eye next AI-cloud catalysts

Nebius Group N.V. shares fell 3.3% to $101.95 Wednesday afternoon, extending a volatile week for the AI infrastructure firm. Investors are watching a Jan. 29 product webinar and a February delivery milestone tied to a $2.9 billion Meta contract. The stock has swung sharply, jumping 9.6% Monday and falling 1.8% Tuesday. Tech stocks broadly declined, with Nvidia down 2.2% and the Nasdaq-100 ETF off 1.4%.
14 January 2026
···
NBIS stock slides after Nebius CEO files to sell shares as AI trade cools

NBIS stock slides after Nebius CEO files to sell shares as AI trade cools

Nebius Group shares fell 1.6% to $86.18 Monday after a filing showed CEO Arkady Volozh plans to sell 41,000 shares, valued at about $3.6 million, in a “sell to cover” transaction. The sale is set for Dec. 31 and Jan. 2, according to a Form 144 notice. The stock traded between $84.25 and $88.55 on volume of 5.4 million shares. Broader tech and AI stocks also slipped to start the week.
29 December 2025
···
Ouster (OUST) vs Nebius Group (NBIS): Latest News, Analyst Forecasts and Stock Analysis as of December 5, 2025

Ouster (OUST) vs Nebius Group (NBIS): Latest News, Analyst Forecasts and Stock Analysis as of December 5, 2025

Ouster shares closed at $25.37 on December 5, up nearly 200% year-on-year but 38% below their 52-week high. The New York State Common Retirement Fund cut its stake by 39.3% in Q2, while insiders sold over 106,000 shares in 90 days. Ouster remains unprofitable, with a net margin of -64% and a price-to-sales ratio far above industry norms. Wall Street’s consensus target is $32.17.
5 December 2025
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 07.11.2025

Shell began a $3.5 billion share buyback split between London and Netherlands contracts, aiming to finish before Q4 2025 results. Nvidia’s stock fell, fueling bear-market concerns and a weekly Nasdaq decline. Nebius Group (NBIS) dropped 4.76% to $111.42 with mixed options sentiment ahead of earnings. Nebius shares remain up 475% in 2025 on strong AI data center demand and a high price-to-sales ratio.
7 November 2025
···

Stock Market Today

  • Ceres Power Surges Past Rolls-Royce, Nvidia, BP in FTSE 250 Rally
    April 29, 2026, 9:27 AM EDT. Ceres Power (LSE:CWR) leads the FTSE 250 stock gains in 2026 with a staggering 176% rise year-to-date, far outpacing Rolls-Royce, Nvidia and BP. The clean energy tech firm, specializing in licensing advanced solid oxide fuel cell and hydrogen technology, posted a remarkable 933% gain over the last year. Despite declining revenues - £32.6 million in 2025 down from £51.9 million the previous year - and no expected profits in 2026 or 2027, investor enthusiasm is fueled by the AI-driven data center boom. Its recent collaboration with Centrica aims to deploy efficient on-site power solutions swiftly for AI hubs and logistics centers. This positions Ceres as a crucial 'picks and shovels' provider amid the AI energy surge. However, over five years, the stock remains down 55%, prompting debate on its current valuation.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop